Section Review: Oncologic, Endocrine and Metabolic: Antibodies as immunogens for cancer therapy

References

• BODMER W: A new look at tumour immunology. Europ. J. Cancer (1992) 10:1761–1762.
   Google Scholar
• GREENBERG PD, RIDDELL SR: Tumour-specific T-cell Immunity: ready for prime time? J. Natl. Cancer Inst. (1992) 84:1059–1061.
   Google Scholar
• BOON T: Tumour antigens recognised by cytolytic T lymphocytes: present perspectives for specific immu-notherapy. Int. J. Cancer (1993) 54:177–180.
   PubMed Web of Science ®Google Scholar
• Clear exposition of T-cell recognition of human tumours by a pioneer in the field.
   Google Scholar
• TSOMIDES 'rJ, EISEN HN: T-cell antigens in cancer. Proc. Natl. Acad. Sci. (1994) 91:3487–3492.
   Google Scholar
• PARDOLL DM: Tumour antigens. A new look for the 1990s. Nature (1994) 369:357–358.
   Google Scholar
• HU J, KINDSVOGEL W, BUSBY S, BAILEY MC, SHI Y, GREENBERG PD: An evaluation of the potential to use tumor-associated antigens as targets for antitumor T-cell therapy using transgenic mice expressing a retrovi-ral tumour antigen in normal lymphoid tissues. J. Ex p. Med. (1993) 177:1681–1690.
   PubMed Web of Science ®Google Scholar
• LEE VK, HARRIOIT TG, KUCHROO VK, HALLIDAY WJ, HELLSTROM 1, HELLSTROM KE: Monoclonal antiidiotypic antibodies related to a =wine oncofetal bladder tu-mour antigen induce specific cell-mediated tumor im-munity. Proc. Natl. Acad. Sci. (1985) 82:6286–6290.
   PubMed Web of Science ®Google Scholar
• KUNDIG TM, BACHMANN MF, LEFRANCOIS L, PUD- DINGTON L, HENGARTNER H, ZINKERNAGEL RM: Nonitn-mimogenic tumor cells may efficiently restimulate tumor antigen specific cytotoxic T-cells. j Immunol. (1993) 150:4450–4456.
   PubMed Web of Science ®Google Scholar
• Elegant demonstration of the potential of non-immunogenic target epitopes for tumour therapy.
   Google Scholar
• DALGLEISH AG: New approaches to the immunotherapy of cancer. Exp. Opin. Invest. Drugs (1994) 3:661–670.
   Google Scholar
• PARDOLL DM: Genetically engineered tumor vaccines. Ann. IVY Acad. Sci. (1993) 690: 601–310.
   Google Scholar
• KOPROWSKI H, HERLYN D, LUBECK M, DEFREITAS E, SEARS HF: Human anti-idiotype antibodies in cancer patients: is the modulation of the immune response beneficial for the patient? Proc. Natl. Acad. Sci. (1984) 81: 216–221.
   PubMed Web of Science ®Google Scholar
• Early demonstration of the potential anti-tumour effects of anti-idio-typic responses in cancer patients.
   Google Scholar
• REITMULLER G, SCHNE1DER-GADICKE E, SCHLIMOK G, SCHMIEGEL W, RAAB R, HOFFKEN K, GRUBER R, PICHL-MAIER H, HIRCHE H, P1CHLMAYR R, BUGGISCH P, WITT J: Randomised trial of monoc.lonal antibody for adju-vant therapy of resected Dukes' C colorectal carcinoma. Lancet (1994) 343:1177–1183.
   Google Scholar
• Best example of clinical therapeutic benefit from specific immu-nological therapy.
   Google Scholar
• MELLSTEDT H, FRODIN J-E, BIBERFELD P, FAGERBERG J, GISCOMBE R, HERNANDEZ A, MASUCCI G, LI S-L, STEINITZ M: Patients treated with a monoclonal (Abc) to the colorectal carcinoma antigen 17-1A develop a cellular response (Dill) to the 'internal image of antigen' (Ab2). Int. J. Cancer (1991) 48:344–349.
   PubMed Web of Science ®Google Scholar
• FAGERBERG J, FRODIN J-E, W1GZELL H, MELLSTEDT H: Induction of an immune network cascade in cancer patients treated with monoclonal antibodies (A132) L May induction of abi reactive T-cells and anti-anti-idio-typic antibodies (ab3) lead to tumour regression after m.Ab therapy? Cancer Immunol. Immunother. (1994) 38:149–159.
   PubMed Web of Science ®Google Scholar
• FAGERBERG J, FRODIN J-E, RAGNHAMMAR P, STEINITZ M, WIGZELL H, MELLSTEDT H: Induction of an immunenetwork cascade in cancer patients treated with mono-clonal antibodies (Ain) IL Is induction of anfildlotype reactive T-cells (T3) of importance for tumour response to mAb therapy? Cancer Immunol. Immunother. (1994) 38:149-159. Highlights the potential importance of T-cell responses in patients receiving anti-tumour antibody.
   Google Scholar
• CHEUNG N-K V, CHEUNG IY, CANETE A, YEH SJ, KUSHNER B, BONILLA MA, HELLER G, LARSON SM: Antibody re-sponse to =urine anti-GD2 monoclonal antibodies: cor-relation with patient survival. Cancer Res. (1994) 54:2228–2233.
   PubMed Web of Science ®Google Scholar
• BAUM RP, NIESEN A, HERTEL A, NANCY A, HESS H, DONNERSTAG B, SYKES TR, SYICES CJ, SURESH MR, NOU-JAIM AA, HOR G: Activating anti-idiotypic human anti-mouse antibodies for icrununotherapy of ovarian carcinoma. Cancer (1994) 73:1121–1125.
   PubMed Web of Science ®Google Scholar
• BHATTACHARYA CHA1TERJEE M, FOON KA, KOHLER H:Idiotypic inununotherapy of cancer. Cancer Immunol. Immunother. (1994) 38:75–82.
   PubMedGoogle Scholar
• CHATTOPADHYAY P, STARKEY J, MORROW WJC(I, RAY-CHAUDHLTRI S: Murine monoclonal anti-idiotype anti-body breaks unresponsiveness and induces a specific antibody response to human melanoma associated pro-teoglycan antigen in cynomolgus monkeys. Proc. Natl. Acad. Sci. (1992) 89:2684–2688.
   PubMed Web of Science ®Google Scholar
• NISONOFF A: Idiotypes: concepts and applications. J. Immunol. (1991) 147:2429–2438.
   PubMed Web of Science ®Google Scholar
• ROBINS RA: T-cell responses at the host:tumour inter-face. Biochem. Biophys. Acta. (1986) 865:289–305.
   PubMedGoogle Scholar
• MODJTAHEDI H, ECCLES S, SANDLE J, BOX G, TITLEY J, DEAN C: Differentiation or immune destruction - 2 pathways for therapy of squamous-cell carcinomas with antibodies to the epidermal growth-factor recep-tor. Cancer Res. (1994) 54:1695–1701.
   PubMed Web of Science ®Google Scholar
• TRAUTH BC, KLAS, C, PETERS AMJ, MATZKU S, MOLLER P,FALK W, DEBATIN KM, KRUMMER PH: Monoclonal anti-body mediated tumour regression by induction of apoptosis. Science (1989) 245:301–304.
   PubMedGoogle Scholar
• LANZAVECCHIA A, ABRIGNANI S, SCHEIDEGGER D, OBRLST R, DORICEN B, MOLDENHAUER G: Antibodies as antigens. The use of mouse monoclonal antibodies to focus human T-cells against selected targets. J. Exp. Med. (1988) 167:345–352.
   Google Scholar
• SHARPE AH, GALTLTON GN, MCDADE KK, FIELDS BN, GREENE MI: Syngeneic monoclonal and-idlotype can Induce cellular immunity to Reovirus. J. Exp. Med. (1984) 160:1195–1205.
   PubMed Web of Science ®Google Scholar
• Early example of induction of T-cell responses by anti-idiotype in a well defined system.
   Google Scholar
• WILLIAMS WV, LONDON SD, WEINERDB, WADSWORTH S, BERZOFSKY JA, ROBEY F, RUBIN DH, GREENE MI: Im-mune response to a molecularly defined internal image idiotope J. Immunol. (1989) 142:4392–4400.
   Web of Science ®Google Scholar
• Theoretical consideration of the molecular basis for T-cell stimulation by anti-idiotypes, and mechanism for the selection of anti-idiotypes with T-cell epitopes.
   Google Scholar
• PRIDE MW, SHI H, ANCHIN JM, LINTHICUM DS, LOVERDE PT, THAKUR A, THANAVALA Y: Molecular mimicry of hepatitis B surface antigen by an anti-idiotype-derived synthetic peptide. Proc. Natl. Acad. Sci. (1993) 89:11900–11902.
   Web of Science ®Google Scholar
• Molecularly defined target for B and T-cell recognition induced by anti-idiotype.
   Google Scholar
• DURRANT LG, DENTON GWL, ROBINS RA: Immunization with human monoclonal anti-idiotypic antibody in colorectal cancer. Ann. IVY Acad. Sci. (1993) 690:334–336.
   PubMed Web of Science ®Google Scholar
• SAEKI Y, CHEN J-J, SHI LA, KOHLER H: Idiotypic intra-molecular help. Induction of tumour-specific antibod-ies by monoclonal anti-idiotypic antibody with the help of Fc specific T helper clones. J. Immunol. (1989) 142:2629–2634.
   Google Scholar
• HERLYN D, ROSS AH, KOPROWSKI H: Anti-idiotypic an-tibodies bear the internal image of a human tumor antigen. Science (1986) 232:100–102.
   PubMed Web of Science ®Google Scholar
• HERLYN D, WETTENDORFF M, SCHMOLL E, ILIOPOULOS D, SCHEDEL I, DREIKHASUEN U, RAAB R, ROSS AH, JAKSCHE H, SCRIBA M, KOPROWSKI H: Anti-idiotype Immunization in cancer patients: modulation of the immune response. Proc. Natl. Acad. Sci. (1987) 84:8055–8059.
   PubMed Web of Science ®Google Scholar
• SAMONIGG H, WILDERS-TRUSCHNIG M, LOIBNER H, PLOT R, ROT A, KUSS I, WERNER G, STOGER H, WRANN M, HERLYN D, KOPROWSKI H: Immune response to tumour antigens in a patient with colorectal cancer after immu-nization with anti-idlotype antibody. din. Immunol. Immunopathol. (1992) 65:271–277.
   PubMedGoogle Scholar
• LOSMAN MJ, MONESTIER M, HANSEN HJ, GOLDENBERG DM: Baboon anti-idiotypic antibodies mimic a carci-noembryonic antigen epitope. Int. J. Cancer (1990) 46:310–314.
   PubMedGoogle Scholar
• CHEUNG N-K V, CANETE A, CHEUNG IY, YE J-N, LIU C: Disialoganglioside Gra anti-idiotypic monoclonal anti-bodies. Int. J. Cancer (1993) 54:499–505.
   PubMed Web of Science ®Google Scholar
• LOSMAN MJ, NOVICK ICE, GOLDENBERG DM, MONESTIER M: Mimicry of a carcinoembryonic antigen epitope by a rat monoclonal anti-idiotype antibody. Int. J. Cancer (1989) 56:580–584.
   Google Scholar
• MONESTIER M, DEBBAS ME, GOLDENBERG DM: Syngeneic anti-idiotypic monoclonal antibodies to murine anti-carcinoembryonic antigen antibodies. Cancer Res. (1989) 49:123–126.
   PubMed Web of Science ®Google Scholar
• BHATTACHARYA-CHATTERJEE M, MUKERJEE S, BIDDLE W, FOON KA, KOHLER H: Murine monoclonal anti-idio-type antibody as a potential network antigen for human carcinoembryonic antigen. J. Immunol. (1990) 145:2758–2765.
   PubMed Web of Science ®Google Scholar
• TSUJISAKI M, IMAI K, TOKUCHI S, HANZAWA Y, ISHDA T, KITAGAWA H, HINODA Y, YACHT A: Induction of anti-gen-specific immune response with use of anti-idio-typic monoclonal antibodies to anti-carcinoembryonic antigen antibodies. Cancer Res. (1991) 51:2599–2604.
   PubMed Web of Science ®Google Scholar
• DE MORAES J, CARNEIRO CRW, BUCHEGGER F, MACH JP, LOPES JD: Induction of an immune response through the idiotypk network with monoclonal anti-idiotype antibodies in the carcinoembryonic antigen system. J. Cell. Biocbem. (1992) 50:324–335.
   PubMed Web of Science ®Google Scholar
• DURRANT LG, DENTON GWL, JACONS E, MEE M, MOSS R,AUSTIN EB, BALDWIN RW, HARDCASTLE JD, ROBINS RA: Anti-colorectal tumour cellular and humoral responses Induced in mice, rats and humans by an idotypk replica of carcinoembryonic antigen. Int. J. Cancer (1992) 50:811–816.
   PubMedGoogle Scholar
• GAIDA F, FENGER U, WAGENER C, NEUMAIER M: A mono-clonal anti-idiotypic antibody bearing the image of an epitope specific to the human carcinoembryonic anti-gen. Int. J. Cancer (1992) 51:459–465.
   PubMed Web of Science ®Google Scholar
• GAIDA FJ, PIEPER D, RODER UW, SHIVELY JE, WAGENER C, NEUMAIER M: Molecular characterization of a cloned idiotypk cascade containing network antigenic deter-minant specific for the human carcinoembryonic anti-gen. J. Biol. Chem. (1993) 268:14138–14145.
   PubMed Web of Science ®Google Scholar
• IRVINE K, SCHLOM J: Induction of delayed-type hy- persensitivity responses by monclonal anti-idiotypk antibodies to tumor cells expressing carcinoembryonic antigen and tumor associated glycoprotein-72. Cancer Immunol. Immunother. (1993) 36:281–292.
   PubMed Web of Science ®Google Scholar
• Most extensive study of the induction of delayed hypersensitivity by anti-idiotypic antibodies.
   Google Scholar
• UEMURA H, OKAJIMA E, DEBRUYNE FMJ, OOSTERWIJK E:Internal image anti-idiotypic antibodies related to re-nal-cell carcinoma-associated antigen G250. Int. J. Can-cer(1994) 56:609–614.
   PubMed Web of Science ®Google Scholar
• UEMURA H, BERNIERS AJMC, OKAJIMA E, DEBRUYNE FMJ,OOSTERWIJK E: Vaccination with anti-idotype antibod-ies mimicking a renal cell carcinoma-associated antigen Induces tumor immunity. Intl. Cancer (1994) 58:555–561.
   PubMed Web of Science ®Google Scholar
• UEMURA H, OKAJIMA E, DEBRUYNE FMJ, OOSTERWIJK E: Immunization with anti-idiotype monoclonal antibod-ies bearing the internal image of the renal cell carci-noma-associated antigen G250 induces specific cellular Immune responses. Int.' Cancer (1994) In press.
   Google Scholar
• BASHFORD JL, ROBINS RA, PRICE MR: Development of an anti-idiotypk antibody reactive with an antibody defin-ing the epitope RPAP in the MUC-1 epithelial mucin core. Int. J. Cancer (1992) 54:778–783.
   Web of Science ®Google Scholar
• POHL C, SCHWONZEN M, SIEBER M, LORENZ P, PFREUND-SCHUH M, DIEHL V: Anti-idiotype vaccine against Hodgkin's lymphoma: induction of B- and T-cell immu-nity across species barriers against CD30 antigen by murine monoclonal internal image antibodies. Int. J. Cancer (1992) 50:958–967.
   PubMed Web of Science ®Google Scholar
• POHL C, RENNER C, SCHWOZEN M, SCHOBERT I, LIEBEN-BERG V, JUNG W, WOLF J, PFREUNDSCHUH M, DIEHL V: CD30-specific AB1-AB2-AB3 internal image antibody network: potential use as an anti-idiotype vaccine against Hodgkin's lymphoma. Int. J. Cancer (1993) 54:418–425.
   PubMed Web of Science ®Google Scholar
• YAMAMOTO S, YAMAMOTO T, SAXTON RE, HOON DSB,HUE RE: Anti-idiotype monoclonal antibody carrying the internal image of ganglioside GM3.1 Natl. Cancer Inst. (1990) 82:1757–1760.
   Google Scholar
• CHATTOPADHYAY P, KAVERI S-V, BYARS N, STARICEY J,FERRONE S, RAYCHALTDHURI S: Human High Molecular Weight-Melanoma Associated Antigen mimicry by an anti-idiotypk antibody: characterization of the immu-nogenicity and the immune response to the mouse monoclonal antibody 1Me1-1. Cancer Res. (1991) 51:6045–6051.
   PubMedGoogle Scholar
• MITTELMAN A, CHEN ZJ, YANK H, WONG GY, FERRONE S: Human high-molecular weight melanoma-associatedantigen (HMW-MAA) mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: induction of humoral anti-HMW-MAA immunity and prolongation of survival In patients with stage IV melanoma. Proc. Natl. Acad. Set. (1992) 89:466–470.
   PubMed Web of Science ®Google Scholar
• Best demonstration of a potential clinical benefit following immuni-sation with a mouse monoclonal anti-idiotypic antibody.
   Google Scholar
• AUSTIN EB. ROBINS RA, DURRANT LG, PRICE MR, BALD- WIN RW: Human monoclonal anti-idiotypic antibody to the tumour associated antibody 791T/36. Immunology (1989) 67:525–530.
   PubMed Web of Science ®Google Scholar
• First human monoclonal anti-idiotypic antibody produced by het-erohybridoma fusion.
   Google Scholar
• AUSTIN EB, ROBINS RA, BALDWIN RW, DURRANT LG: Induction of delayed hypersensitivity to human tumour cells with a human monoclonal anti-idiotypic antibody. J Natl. Cancer Inst. (1991) 83:1245–1248.
   PubMed Web of Science ®Google Scholar
• Demonstration of delayed hypersensitivity priming by a human monoclonal anti-idiotype.
   Google Scholar
• DURRANT LG, DORAN M, AUSTIN EB, ROBINS RA: Delayedhypersensitivity responses induced by syngeneic monoclonal anti-idiotypic antibody related to tumour associated antigen 791Tg72. Int.J. Cancer(1994) In press.
   Google Scholar
• WORKING PARTY REPORT ON THE CLINICAL USE OF ANI1BODIES: Operation manual for control of produc-tion, preclinical toxicity and Phase I trials of anti-tu-mour antibodies and drug-antibody conjugates. Br. J. Cancer (1986) 54:557–568.
   PubMed Web of Science ®Google Scholar
• ROBINS RA, DENTON GWL, HARDCASTLE JD, AUSTIN EB, BALDWIN RW, DURRANT LG: Anti-tumour immune re-sponse and interleukin 2 production induced in col-orectal cancer patients by ircumunisation with human monoclonal anti-idiotypic antibody. Cancer Res, (1991) 51:5425–5429.
   PubMed Web of Science ®Google Scholar
• First report of clinical studies with human monoclonal anti-idiotypic immunisation,
   Google Scholar
• DENTON GWL, DURRANT LG, HARDCASTLE JD, AUSTIN EB, SEWELL HF, ROBINS RA: Clinical outcome of colorec- tal cancer patients treated with human monoclonal anti-idiotypic antibody. Int. J. Cancer (1994) 57:10-14. Indication of survival benefit in patients immunised with human monoclonal anti-idiotypic antibody.
   Google Scholar
• DURRANT LG, BUCKLEY D, DENTON GWL, ROBINS RA: Enhanced cell mediated tumour killing in patients Immunised with human monoclonal anti-idiotypic an-tibody 105AD7. Cancer Res. (1994) In press.
   Google Scholar
• REES ADM, PRAPUTPITTAYA K, SCOGING A, DOBSON N, IVANYI J, YOUNG D, LAMB JR: T-cell activation by anti-idiotypic antibody: evidence for the internal image. Immunology (1987) 60:389–396.
   PubMed Web of Science ®Google Scholar
• BAN N, ESCOBAR C, GARCIA R, HASEL K, DAY J, GREEN-WOOD A, MCPHERSON A: Crystal structure of an idio-type-anti-idiotype Fab complex. Proc. Natl. Acad. Sci. (1994) 91:1604–1608.
   PubMed Web of Science ®Google Scholar
• Elegant demonstration of the structural basis for sequence mimicry by anti-idiotype.
   Google Scholar